Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX005 (ip) |
median survival time |
saline |
0.38 mg/kg/injection |
357.0 |
Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
Q01DX005 (ip) |
median survival time |
saline |
0.38 mg/kg/injection |
192.0 |
Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
Q01DX005 (ip) |
median survival time |
saline |
0.75 mg/kg/injection |
357.0 |
Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
Q01DX005 (ip) |
median survival time |
saline |
0.75 mg/kg/injection |
432.0 |
Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
Q01DX005 (ip) |
median survival time |
saline |
1.5 mg/kg/injection |
357.0 |
Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
Q01DX005 (ip) |
median survival time |
saline |
1.5 mg/kg/injection |
432.0 |
Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
Q01DX005 (ip) |
median survival time |
saline |
3.0 mg/kg/injection |
357.0 |
Antitumor endpoint evaluated on day 45; 05/06 animals surviving on day 5 |
Q01DX005 (ip) |
median survival time |
saline |
3.0 mg/kg/injection |
86.0 |
Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |